FDA Device Intelligence
Home › ILLUMINA, INC. › Local Run Manager CF Clinical Seq 2.0 Micro Analysis Module

Local Run Manager CF Clinical Seq 2.0 Micro Analysis Module

ILLUMINA, INC. · Model 20072974 · UDI-DI 00816270020385

PFS Prescription
1
510(k) clearances
0
Adverse events
2
Recalls
1
Facilities

Description

The Local Run Manager CF Clinical Seq 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis Clinical Sequencing Assay when processing 24–36 samples. The assay detects mutations in the protein coding regions and intron/exon boundaries of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including two large deletions and two-deep intronic mutations. The analysis module performs secondary analysis and report generation from sequencing runs that use TruSight Cystic Fibrosis.

Recalls

DateFirmReason
2014-11-13Illumina IncIt was discovered a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Universal Kit 1.0 on the MiSeqDx instrument. The software cannot repor
2014-11-06Illumina IncIllumina has confirmed a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay on the MiSeqDx instrumen

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.